Click for best price
Radioembolization Cancer Treatment Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Radioembolization Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioembolization Cancer Treatment. This report contains market size and forecasts of Radioembolization Cancer Treatment in global, including the following market information:
Global Radioembolization Cancer Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Radioembolization Cancer Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Transarterial Radioembolization (TARE) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Radioembolization Cancer Treatment include Terumo Corporation, Merit Medical Systems, Cook Medical, Boston Scientific Corporation, Medtronic, Stryker Corporation, Depuy Synthes (J&J) and BTG International Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioembolization Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioembolization Cancer Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Radioembolization Cancer Treatment Market Segment Percentages, by Type, 2022 (%)
Transarterial Radioembolization (TARE)
Selective Internal Radiation Therapy (SIRT)
Global Radioembolization Cancer Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Radioembolization Cancer Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Others
Global Radioembolization Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Radioembolization Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioembolization Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radioembolization Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Terumo Corporation
Merit Medical Systems
Cook Medical
Boston Scientific Corporation
Medtronic
Stryker Corporation
Depuy Synthes (J&J)
BTG International Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radioembolization Cancer Treatment, market overview.
Chapter 2: Global Radioembolization Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Radioembolization Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radioembolization Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Radioembolization Cancer Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radioembolization Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioembolization Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioembolization Cancer Treatment Overall Market Size
2.1 Global Radioembolization Cancer Treatment Market Size: 2022 VS 2029
2.2 Global Radioembolization Cancer Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioembolization Cancer Treatment Players in Global Market
3.2 Top Global Radioembolization Cancer Treatment Companies Ranked by Revenue
3.3 Global Radioembolization Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Radioembolization Cancer Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Radioembolization Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioembolization Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Radioembolization Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioembolization Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Radioembolization Cancer Treatment Market Size Markets, 2022 & 2029
4.1.2 Transarterial Radioembolization (TARE)
4.1.3 Selective Internal Radiation Therapy (SIRT)
4.2 By Type - Global Radioembolization Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Radioembolization Cancer Treatment Revenue, 2018-2023
4.2.2 By Type - Global Radioembolization Cancer Treatment Revenue, 2024-2029
4.2.3 By Type - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioembolization Cancer Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Radioembolization Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Radioembolization Cancer Treatment Revenue, 2018-2023
5.2.2 By Application - Global Radioembolization Cancer Treatment Revenue, 2024-2029
5.2.3 By Application - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Radioembolization Cancer Treatment Market Size, 2022 & 2029
6.2 By Region - Global Radioembolization Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Radioembolization Cancer Treatment Revenue, 2018-2023
6.2.2 By Region - Global Radioembolization Cancer Treatment Revenue, 2024-2029
6.2.3 By Region - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Radioembolization Cancer Treatment Revenue, 2018-2029
6.3.2 US Radioembolization Cancer Treatment Market Size, 2018-2029
6.3.3 Canada Radioembolization Cancer Treatment Market Size, 2018-2029
6.3.4 Mexico Radioembolization Cancer Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Radioembolization Cancer Treatment Revenue, 2018-2029
6.4.2 Germany Radioembolization Cancer Treatment Market Size, 2018-2029
6.4.3 France Radioembolization Cancer Treatment Market Size, 2018-2029
6.4.4 U.K. Radioembolization Cancer Treatment Market Size, 2018-2029
6.4.5 Italy Radioembolization Cancer Treatment Market Size, 2018-2029
6.4.6 Russia Radioembolization Cancer Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Radioembolization Cancer Treatment Market Size, 2018-2029
6.4.8 Benelux Radioembolization Cancer Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Radioembolization Cancer Treatment Revenue, 2018-2029
6.5.2 China Radioembolization Cancer Treatment Market Size, 2018-2029
6.5.3 Japan Radioembolization Cancer Treatment Market Size, 2018-2029
6.5.4 South Korea Radioembolization Cancer Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Radioembolization Cancer Treatment Market Size, 2018-2029
6.5.6 India Radioembolization Cancer Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Radioembolization Cancer Treatment Revenue, 2018-2029
6.6.2 Brazil Radioembolization Cancer Treatment Market Size, 2018-2029
6.6.3 Argentina Radioembolization Cancer Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue, 2018-2029
6.7.2 Turkey Radioembolization Cancer Treatment Market Size, 2018-2029
6.7.3 Israel Radioembolization Cancer Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Radioembolization Cancer Treatment Market Size, 2018-2029
6.7.5 UAE Radioembolization Cancer Treatment Market Size, 2018-2029
7 Radioembolization Cancer Treatment Companies Profiles
7.1 Terumo Corporation
7.1.1 Terumo Corporation Company Summary
7.1.2 Terumo Corporation Business Overview
7.1.3 Terumo Corporation Radioembolization Cancer Treatment Major Product Offerings
7.1.4 Terumo Corporation Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.1.5 Terumo Corporation Key News & Latest Developments
7.2 Merit Medical Systems
7.2.1 Merit Medical Systems Company Summary
7.2.2 Merit Medical Systems Business Overview
7.2.3 Merit Medical Systems Radioembolization Cancer Treatment Major Product Offerings
7.2.4 Merit Medical Systems Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.2.5 Merit Medical Systems Key News & Latest Developments
7.3 Cook Medical
7.3.1 Cook Medical Company Summary
7.3.2 Cook Medical Business Overview
7.3.3 Cook Medical Radioembolization Cancer Treatment Major Product Offerings
7.3.4 Cook Medical Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.3.5 Cook Medical Key News & Latest Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Company Summary
7.4.2 Boston Scientific Corporation Business Overview
7.4.3 Boston Scientific Corporation Radioembolization Cancer Treatment Major Product Offerings
7.4.4 Boston Scientific Corporation Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.4.5 Boston Scientific Corporation Key News & Latest Developments
7.5 Medtronic
7.5.1 Medtronic Company Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Radioembolization Cancer Treatment Major Product Offerings
7.5.4 Medtronic Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.5.5 Medtronic Key News & Latest Developments
7.6 Stryker Corporation
7.6.1 Stryker Corporation Company Summary
7.6.2 Stryker Corporation Business Overview
7.6.3 Stryker Corporation Radioembolization Cancer Treatment Major Product Offerings
7.6.4 Stryker Corporation Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.6.5 Stryker Corporation Key News & Latest Developments
7.7 Depuy Synthes (J&J)
7.7.1 Depuy Synthes (J&J) Company Summary
7.7.2 Depuy Synthes (J&J) Business Overview
7.7.3 Depuy Synthes (J&J) Radioembolization Cancer Treatment Major Product Offerings
7.7.4 Depuy Synthes (J&J) Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.7.5 Depuy Synthes (J&J) Key News & Latest Developments
7.8 BTG International Limited
7.8.1 BTG International Limited Company Summary
7.8.2 BTG International Limited Business Overview
7.8.3 BTG International Limited Radioembolization Cancer Treatment Major Product Offerings
7.8.4 BTG International Limited Radioembolization Cancer Treatment Revenue in Global Market (2018-2023)
7.8.5 BTG International Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Radioembolization Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Radioembolization Cancer Treatment Market Drivers in Global Market
Table 3. Radioembolization Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Radioembolization Cancer Treatment in Global Market
Table 5. Top Radioembolization Cancer Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Radioembolization Cancer Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Radioembolization Cancer Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Radioembolization Cancer Treatment Product Type
Table 9. List of Global Tier 1 Radioembolization Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radioembolization Cancer Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Radioembolization Cancer Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Radioembolization Cancer Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Radioembolization Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Terumo Corporation Company Summary
Table 31. Terumo Corporation Radioembolization Cancer Treatment Product Offerings
Table 32. Terumo Corporation Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Terumo Corporation Key News & Latest Developments
Table 34. Merit Medical Systems Company Summary
Table 35. Merit Medical Systems Radioembolization Cancer Treatment Product Offerings
Table 36. Merit Medical Systems Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Merit Medical Systems Key News & Latest Developments
Table 38. Cook Medical Company Summary
Table 39. Cook Medical Radioembolization Cancer Treatment Product Offerings
Table 40. Cook Medical Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Cook Medical Key News & Latest Developments
Table 42. Boston Scientific Corporation Company Summary
Table 43. Boston Scientific Corporation Radioembolization Cancer Treatment Product Offerings
Table 44. Boston Scientific Corporation Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Boston Scientific Corporation Key News & Latest Developments
Table 46. Medtronic Company Summary
Table 47. Medtronic Radioembolization Cancer Treatment Product Offerings
Table 48. Medtronic Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Medtronic Key News & Latest Developments
Table 50. Stryker Corporation Company Summary
Table 51. Stryker Corporation Radioembolization Cancer Treatment Product Offerings
Table 52. Stryker Corporation Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Stryker Corporation Key News & Latest Developments
Table 54. Depuy Synthes (J&J) Company Summary
Table 55. Depuy Synthes (J&J) Radioembolization Cancer Treatment Product Offerings
Table 56. Depuy Synthes (J&J) Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Depuy Synthes (J&J) Key News & Latest Developments
Table 58. BTG International Limited Company Summary
Table 59. BTG International Limited Radioembolization Cancer Treatment Product Offerings
Table 60. BTG International Limited Radioembolization Cancer Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. BTG International Limited Key News & Latest Developments
List of Figures
Figure 1. Radioembolization Cancer Treatment Segment by Type in 2022
Figure 2. Radioembolization Cancer Treatment Segment by Application in 2022
Figure 3. Global Radioembolization Cancer Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Radioembolization Cancer Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Radioembolization Cancer Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radioembolization Cancer Treatment Revenue in 2022
Figure 8. By Type - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 16. US Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 28. China Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Radioembolization Cancer Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Terumo Corporation Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merit Medical Systems Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cook Medical Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boston Scientific Corporation Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Medtronic Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Stryker Corporation Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Depuy Synthes (J&J) Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BTG International Limited Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
